Coral Omene, Associate Professor, Medical Oncologist at Rutgers Cancer Institute, shared on LinkedIn:
“Happy to have participated in the fantastic conference with speakers from all around the world at MAMMO 2026: Global Breast Cancer Virtual Congress where I discussed ‘Moving Beyond Lifestyle: The FITWISE Trial and Scaling GLP-1 Receptor Agonists to Combat Obesity and Disparities’.
See below for great conference summary highlights.”
MAMMÔ 2026 Day 2 Highlights: From Adjuvant Optimization to the ADC Revolution in Breast Cancer
Day 2 of MAMMÔ 2026 brought together leading international experts to discuss the latest advances in breast cancer management, from optimizing adjuvant therapies and overcoming endocrine resistance to the expanding role of antibody-drug conjugates (ADCs) and precision treatment strategies.
The scientific program also explored emerging oral SERDs, molecular biomarkers, treatment sequencing, survivorship, supportive care, and complex clinical decisions addressed through a multidisciplinary molecular tumor board.
Explore the key discussions and scientific highlights from Day 2 on OncoDaily.
